CompletedNot Applicable

Specific Genotypes/Phenotypes of Pneumocystis Jirovecii in Solid Organ Transplant Recipients: Potential Involvement of Mycophenolic Acid

France100 participantsStarted 2022-07-04

Plain-language summary

To determine the presence of IMDPH mutants of Pneumocystis jirovecii in solid organ transplant recipient with prior exposition to mycophenolic acid.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \>= 18 years old with PCP diagnoses, organ transplant recipient or not, acceptation to participate Exclusion Criteria: * \< 18 years old, no acceptation to participate

What they're measuring

Presence of Pneumocystis IMPDH gene mutant or not

Timeframe: At patient enrollment

Trial details

NCT IDNCT05452148

SponsorUniversity Hospital, Brest

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-07-31

View on ClinicalTrials.gov More Transplantation trials